BridgeBio
Developing breakthrough medicines for genetic diseases
- B2B
- B2C
About BridgeBio
This company is focused on finding, developing, and delivering breakthrough medicines for genetic diseases, bridging the gap between science and patient needs
Key facts
- Industry
- Biotechnology Research
- Company size
- 251–1,000 employees
- Headquarters
- Palo Alto, California, United States
- Founded
- 2014
- Revenue
- $502MFY2025, publicly reported
- Website
- bridgebio.com
- linkedin.com/company/bridgebio
BridgeBio at a glance
BridgeBio is a B2B/B2C company in the Biotechnology Research industry, headquartered in Palo Alto, California, United States.
BridgeBio was founded in 2014.
BridgeBio has 251–1,000 employees.
BridgeBio's revenue is $502M (FY2025, publicly reported).
Selling to companies like BridgeBio?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies